This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Infant, Small for Gestational Age
and you are
between 4 and 16
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

A study demonstrates the non-inferiority of DA-3002 when compared with Genotropin® in short children born small for gestational age.

Provided treatments

  • Drug: DA-3002
  • Drug: Genotropin®
Tris trial is registered with FDA with number: NCT02770157. The sponsor of the trial is Dong-A ST Co., Ltd. and it is looking for 75 volunteers for the current phase.
Official trial title:
Phase III Clinical Trial for Assessment of Efficacy and Safety of DA-3002 (Recombinant Human Growth Hormone) in Short Children Born Small for Gestational Age.